T.M. Jenkins

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1

Gerd Fätkenheuer, Anton Pozniak, Margaret Johnson et al. · Nature Medicine · 2005 · 490 citations

Treatment And Prevention, Medicine, Immunology +10

Emergence of CXCR4-Using Human Immunodeficiency Virus Type 1 (HIV-1) Variants in a Minority of HIV-1-Infected Patients following Treatment with the CCR5 Antagonist Maraviroc Is from a Pretreatment CXCR4-Using Virus Reservoir

Mike Westby, Marilyn Lewis, Jeannette M. Whitcomb et al. · Journal of Virology · 2006 · 330 citations · Full text

Ccr5 Antagonist Maraviroc, Ccr5 Tropic, Human Retrovirus +11

Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking

T.M. Jenkins · The EMBO Journal · 1997 · 229 citations · Full text

Viral Dna, Hiv-1 Integrase, Virus Structure +9

Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure

Norah A. Terrault, Tarek Hassanein, Charles D. Howell et al. · Journal of Hepatology · 2014 · 82 citations

Thrombocytopenic Patients, Thrombosis, Thrombopoiesis +13

Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of <b> <i>in silico</i> </b> physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man

Gill Allan, John D. Davis, Maurice Dickins et al. · Xenobiotica · 2008 · 61 citations